The FDA has granted Fast Track Designation to Adicet Bio’s ADI-001, an allogeneic gamma delta CAR T-cell therapy, for ...

A 23-year-old white woman with systemic lupus erythematosus (SLE ... CNS vasculitis who have progressing symptoms, concomitant treatments have to be initiated promptly, before the diagnosis ...

Topical mupirocin helps reduce inflammation in lupus, offering a potential new approach for managing symptoms and improving ...

Adicet Bio, Inc. (ACET), a clinical stage biotechnology company, Wednesday said it received Fast Track Designation from the U.S. Food ...

Systemic lupus erythematosus, more commonly known as lupus, has a variety of symptoms and room for improvement when it comes ...

A new study found that low or absent disease activity, hydroxychloroquine (HCQ) use, and gradual reduction of GC dosing can minimize flare risk and support the successful discontinuation of GCs in ...

The U.S. Food and Drug Administration (FDA has cleared the investigational new drug (IND) application for Allogene ...

Treatment for CHLE can include medications ... changes in the immune system are responsible for symptoms. Chilblain lupus erythematosus (CHLE) is a type of cutaneous lupus erythematosus (CLE ...

Lupus can cause hearing loss. This is often due to inflammation or immune responses affecting the inner ear. Symptoms can ...

Bullous systemic lupus erythematosus (BSLE ... It also looks at how doctors diagnose the condition, treatment options, and more. BLSE typically causes a sudden and severe eruption of blisters ...

had active SLE disease and have been on stable SLE treatment regimen. Lupus activity was defined by presence of SS score of at least 4. Some of the exclusions were patients treated with ...

Interferon-alpha activity may be used routinely in clinical settings as a biomarker for cutaneous lupus erythematosus and ...